3rd Quarter - Report — FAEGRE BAKER DANIELS CONSULTING for USAGAINST ALZHEIMER'S (2015)

Firm

FAEGRE BAKER DANIELS CONSULTING

Client

USAGAINST ALZHEIMER'S

Income

$30,000

Expenses

—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General issues regarding Alzheimer's Disease; Global Alzheimer's and Dementia issues; 21st Century Care Act

Lobbyist	Covered position, as disclosed
JOHN KEVIN BRENNAN	—
ROBERT JOHN EHRICH	—
NICK MANETTO	—

Contacted: Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

General issues regarding Alzheimer's Disease; Global Alzheimer's and Dementia issues

Lobbyist	Covered position, as disclosed
JOHN KEVIN BRENNAN	—
ROBERT JOHN EHRICH	—
NICK MANETTO	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Natl Institutes of Health (NIH)

Foreign Relations FOR

Global Alzheimer's and Dementia issues

Lobbyist	Covered position, as disclosed
JOHN KEVIN BRENNAN	—
ROBERT JOHN EHRICH	—
NICK MANETTO	—

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Fiscal year 2016 appropriations

Lobbyist	Covered position, as disclosed
JOHN KEVIN BRENNAN	—
ROBERT JOHN EHRICH	—
NICK MANETTO	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.